Aarti Drugs

Aarti Drugs

AARTIDRUGS

 ₹ 420.14
- ₹ 7.11
1.66%
Healthcare
 ₹ 0.00
(%)1D
Updated: 20 Dec 2024, 03:30:58 pm IST
Stock Score
Open Price
 ₹ 424.07
Prev. Close
 ₹ 427.25
 ₹ 416.81
Day Low
 ₹ 426.26
Day High

 ₹ 373.58
52 Week Low
 ₹ 641.73
52 Week High

Quick Bite

Price To Earnings Ratio

22.53

Sector PE

69.55

PB Ratio

3.01

Sector PB

8.96

EPS

18.65

Dividend Yield

0.23

Today's Volume

122.875 K

5 Day Avg. Volume

95.080 K

PEG Ratio

5.90

Market Cap.

₹ 4,060.00 Cr.

Aarti Drugs Share Price

Aarti Drugs Limited is an Indian pharmaceutical company that manufactures active ingredients (APIs), pharmaceutical intermediates and specialty chemicals. The company focuses on manufacturing products through its wholly owned subsidiary Pinnacle Life Science Private Limited. The company's API products include ciprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole and ofloxacin. Its pharmaceutical intermediates include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemicals such as benzenesulfonyl chloride and methyl nicotinate. The company's products under development include the treatment of alcoholism, anticoagulants, hyperphosphatemia, cholesterol, cardiovascular diseases, cardioprotective agents and diabetes drugs.

Aarti Drugs FAQs

How to Buy Aarti Drugs Share?

up
To purchase Aarti Drugs shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Aarti Drugs (ticker symbol: AARTIDRUGS) on the trading platform provided by your broker and purchase the shares.

What's Aarti Drugs share price today?

up
The stock price of Aarti Drugs as of 21 Dec 2024 is ₹420.14

What is the Market Cap of Aarti Drugs?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 21 Dec 2024, Aarti Drugs (ticker symbol: AARTIDRUGS) has a market capitalisation of approximately ₹40,60,00,00,000.00

What is the PE and PB ratio of Aarti Drugs?

up
Aarti Drugs Ltd's price-to-book ratio as of 21 Dec 2024 is 3.01, reflecting the market's valuation compared to its asset value. As of 21 Dec 2024, the trailing twelve months P/E (price-to-earnings) ratio is 22.53, indicating the market values the company at around ₹22.53 for every ₹1 of earnings

What is the 52 Week High and Low of Aarti Drugs Share?

up
Aarti Drugs Ltd (AARTIDRUGS) hit its 52-week high at ₹641.73, and its 52-week low at ₹373.58.
Want to learn and earn in Stocks?
Login/Register
Start Learning